Concurrent helical tomography with chemotherapy in unresectable stage II non-small cell lung cancer (NSCLC): a phase I/II trial of radiation dose escalation and fixed dose chemotherapy

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 25 Jul 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Docetaxel (Primary) ; Cisplatin
Indications Adenocarcinoma; Carcinoma; Large cell carcinoma; Non-small cell lung cancer; Squamous cell cancer
Focus Therapeutic Use
Acronyms TomoCT

12 Mar 2008 Status changed from initiated to recruiting as reported by ClinicalTrials.gov
17 Oct 2006 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com